Photo of James Gray

James Gray (North Wiltshire, Conservative)

To ask the Secretary of State for Health pursuant to the answer of 10 July 2007, Official Report, column 1450W, on leukaemia: drugs, what the reasons were for deciding not to refer dasatnib to the National Institute for Health and Clinical Excellence; and in what circumstances the drug would be considered for referral in the future.

Photo of Dawn Primarolo

Dawn Primarolo (Minister of State (Public Health), Department of Health; Bristol South, Labour)

The Department has not received a proposal from the National Institute for Health and Clinical Excellence (NICE) for an appraisal of dasatinib for chronic myeloid leukaemia. However, I understand that NICE is currently considering a proposal for an appraisal of this treatment against its published criteria for the selection of topics.


No annotations

Sign in or join to post a public annotation.